Wasatch Pharmaceutical Inc Watch

from 10QSB 1 page Exhibit 1.1 Certification Pursuant to 18 U.S.C. Ss.1350, as Adopted Pursuant to Ss.906 of the Sarbanes-Oxley Act of 2002 in Connection With the Quarterly Report of Wasatch Pharmaceutical, Inc., a Utah Corporation (The "Company"), on Form 10-Qsb for the Period Ended September 30, 2002, as Filed With the Securities and Exchange Commission on the Date Hereof (The "Report"), I, Gary V. Heesch, President (Chief Executive Officer) of the Company, Certify, Pursuant to 18 U.S.C. Ss.1350, as Adopted Pursuant to Ss.906 of the Sarbanes-Oxley Act of 2002, That: (1) the Report Fully Complies With the Requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and (2) the Information Contained in the Report Fairly Presents, in All Material Respects, the Financial Condition and Results of Operations of the Company. by /S/ Gary V. Heesch Gary V. Heesch President (Chief Executive Officer) Wasatch Pharmaceutical, Inc. December 1, 2002 Certification Pursuant to 18 U.S.C. Ss.1350, as Adopted Pursuant to Ss.906 of the Sarbanes-Oxley Act of 2002 in Connection With the Quarterly Report of Wasatch Pharmaceutical, Inc., a Utah Corporation (The "Company"), on Form 10-Qsb for the Period Ended September 30, 2002, as Filed With the Securities and Exchange Commission on the Date Hereof (The "Report"), I, David K. Giles Treasurer (Chief Accounting Officer) of the Company, Certify, Pursuant to 18 U.S.C. Ss.1350, as Adopted Pursuant to Ss.906 of the Sarbanes-Oxley Act of 2002, That: (1) the Report Fully Complies With the Requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and (2) the Information Contained in the Report Fairly Presents, in All Material Respects, the Financial Condition and Results of Operations of the Company. by /S/ David K. Giles David K. Giles Treasurer (Chief Accounting Officer) Wasatch Pharmaceutical, Inc. December 1, 2002

from 10QSB 1 page Exhibit 1.1 Certification Pursuant to 18 U.S.C. Ss.1350, as Adopted Pursuant to Ss.906 of the Sarbanes-Oxley Act of 2002 in Connection With the Quarterly Report of Wasatch Pharmaceutical, Inc., a Utah Corporation (The "Company"), on Form 10-Qsb for the Period Ended June 30, 2002, as Filed With the Securities and Exchange Commission on the Date Hereof (The "Report"), I, Gary V. Heesch, President (Chief Executive Officer) of the Company, Certify, Pursuant to 18 U.S.C. Ss.1350, as Adopted Pursuant to Ss.906 of the Sarbanes-Oxley Act of 2002, That: (1) the Report Fully Complies With the Requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and (2) the Information Contained in the Report Fairly Presents, in All Material Respects, the Financial Condition and Results of Operations of the Company. by /S/ Gary V. Heesch Gary V. Heesch President (Chief Executive Officer) Wasatch Pharmaceutical, Inc. September 11, 2002 Certification Pursuant to 18 U.S.C. Ss.1350, as Adopted Pursuant to Ss.906 of the Sarbanes-Oxley Act of 2002 in Connection With the Quarterly Report of Wasatch Pharmaceutical, Inc., a Utah Corporation (The "Company"), on Form 10-Qsb for the Period Ended June 30, 2002, as Filed With the Securities and Exchange Commission on the Date Hereof (The "Report"), I, David K. Giles Treasurer (Chief Accounting Officer) of the Company, Certify, Pursuant to 18 U.S.C. Ss.1350, as Adopted Pursuant to Ss.906 of the Sarbanes-Oxley Act of 2002, That: (1) the Report Fully Complies With the Requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and (2) the Information Contained in the Report Fairly Presents, in All Material Respects, the Financial Condition and Results of Operations of the Company. by /S/ David K. Giles David K. Giles Treasurer (Chief Accounting Officer) Wasatch Pharmaceutical, Inc. September 11, 2002

from 10QSB ~5 pages Item 2 - Changes in Securities